| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
1985-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1690fc564ad17f85e265db92069b6db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb23a4105cecf5d0672e82a5401e3a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719616654f04ab0f54f759afc5b90e6d |
| publicationDate |
1987-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4665056-A |
| titleOfInvention |
Dihydroorotic acid derivative and processes for preparing the same |
| abstract |
There are disclosed 1-methyl-4,5-dihydroorotyl-histidylprolinamide or a pharmaceutically acceptable acid addition salt thereof, processes for their preparation and pharmaceutical compositions containing them. The prolinamide and the pharmaceutically acceptable acid addition salts thereof are useful for the treatment of central nervous system disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1321151-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1321151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0862429-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9380976-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150079043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020240207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9265458-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0862429-A4 |
| priorityDate |
1984-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |